(Total Views: 185)
Posted On: 12/20/2022 12:45:49 PM
Post# of 107225
$SGEN News Article - Seagen, Astellas and Merck Announce FDA Acceptance of sBLAs for PADCEV (enfortumab vedotin-ejfv) with KEYTRUDA (pembrolizumab) for the First-Line Treatment of Certain Patients With Locally Advanced or Metastatic Urothelial Cancer https://marketwirenews.com/news-releases/seag...12267.html
(0)
(0)
My Twitter: WhyteStocks
